Haemonetics (HAE) Operating Margin Growth (3y) (2012 - 2026)

Haemonetics (HAE) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn -343.00
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 17.00
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -178.00
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -283.00
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 1,505.00
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -184.00
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,016.00
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -3,846.00
10 Haemonetics 3.55 Bn 3.30 Bn 198.21 Mn -1,823.00

Historic Data

Download Data
DateValue
Mar 28, 2026 -1,823.00
Dec 27, 2025 571.00
Sep 27, 2025 216.00
Jun 28, 2025 499.00
Mar 29, 2025 1,433.00
Dec 28, 2024 321.00
Sep 28, 2024 475.00
Jun 29, 2024 1,122.00
Mar 30, 2024 1,813.00
Dec 30, 2023 -314.00
Sep 30, 2023 -1,696.00
Jul 1, 2023 1,125.00
Apr 1, 2023 68.00
Dec 31, 2022 -162.00
Oct 1, 2022 -398.00
Jul 2, 2022 1,735.00
Apr 2, 2022 -232.00
Jan 1, 2022 228.00
Oct 2, 2021 -58.00
Jul 3, 2021 -170.00